E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/30/2023 in the Prospect News Structured Products Daily.

New Issue: Barclays prices $7.75 million callable contingent coupon notes on index, ETF

By Wendy Van Sickle

Columbus, Ohio, June 30 – Barclays Bank plc priced $7.75 million of callable contingent coupon notes due June 26, 2026 linked to the performance of the S&P 500 index and the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.

The notes pay a contingent semiannual coupon at an annualized rate of 12% if each underlier closes at or above its coupon barrier level, 60% of its initial level, on the related observation date.

The notes will be callable in whole at par plus any coupon due on any semiannual call date.

If the notes are not redeemed early and each underlier finishes at or above its 60% final barrier level, the payout at maturity will be par plus any final coupon.

Otherwise, investors will be fully exposed to the decline of the worst performer from its initial level.

Barclays is the agent.

Issuer:Barclays Bank plc
Issue:Callable contingent coupon notes
Underlying assets:S&P 500 index, SPDR S&P Biotech ETF
Amount:$7,748,000
Maturity:June 26, 2026
Contingent coupon:12% per year, payable semiannually if each underlier closes at or above coupon barrier on the observation date for that period
Price:Par
Payout at maturity:If the final level of each underlier is greater than or equal to its final barrier, par plus any final coupon; otherwise, lose 1% for every 1% decline of the worst performer from its initial level
Call option:In whole at par plus any coupon due on any semiannual call dates
Initial levels:4,348.33 for S&P, $85.12 for SPDR S&P Biotech
Coupon barriers:2,609.0 for S&P, $51.07 for SPDR S&P Biotech; 60% of initial levels
Final barrier levels:2,609.0 for S&P, $51.07 for SPDR S&P Biotech; 60% of initial levels
Pricing date:June 23
Settlement date:June 28
Agent:Barclays
Fees:0.45%
Cusip:06745MH84

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.